Image

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Evaluating safety and effects of AP-SA02 treatment for S. Aureus infections.

Recruiting
18 years and older
All
Phase 1/2

This medical study is for adults with a serious infection in their blood called Staphylococcus aureus (SA) bacteremia. Bacteremia means bacteria in the blood. The study is testing a new treatment called AP-SA02, given through the vein (intravenous). It will be combined with the best available antibiotic therapy (BAT) to see if it works better than just using the antibiotics alone.

The study has two parts. The first part checks if the new treatment is safe and if people can handle it well. The second part checks how well the treatment works along with its safety.

  • Participants need to be in the hospital and at least 18 years old.
  • The study involves multiple doses given through an IV.
  • Participants cannot have other infections besides SA, heart infection, or brain problems.

Those who join the study should not be pregnant and must use contraception if they can have children. If you are allergic to phage products or have other infections, you cannot join this study.

Study details
    Bacteremia
    Staphylococcus Aureus
    Staphylococcus Aureus Bacteremia
    Bacteremia Staph
    Bacteremia Due to Staphylococcus Aureus

NCT05184764

Armata Pharmaceuticals, Inc.

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.